Dbv Technologies ADR (DBVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DBVT | AMGN | VRTX | GILD | BMY |
| Company | Dbv Technologies ADR | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.36 | 276.00 | 472.31 | 92.40 | 58.00 |
| High | 3.46 | 276.28 | 472.33 | 94.65 | 58.05 |
| Low | 3.29 | 270.58 | 460.74 | 91.94 | 56.62 |
| Last | 3.29 | 273.41 | 468.29 | 92.38 | 56.65 |
| Change | -0.16 | -2.34 | -0.93 | +0.04 | -1.47 |
| % Change | -4.64% | -0.85% | -0.20% | +0.04% | -2.53% |
| Volume | 1,328,000 | 4,491,800 | 1,043,700 | 7,525,100 | 10,578,181 |
| 20-Day Average Volume | 101,624 | 4,643,170 | 1,337,375 | 7,208,445 | 9,797,300 |
| Previous Close | 3.45 | 275.75 | 469.22 | 92.34 | 58.12 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.18 | 282.87 | 464.68 | 91.18 | 58.39 |
| 20-Day Raw Stochastic | 47.29% | 31.45% | 43.74% | 73.51% | 17.08% |
| 20-Day Relative Strength | 47.68% | 33.93% | 49.06% | 55.58% | 50.25% |
| Weighted Alpha | -76.14 | -8.22 | +11.33 | +24.53 | +18.42 |
| Today's Opinion | 72% Sell | 88% Sell | 8% Sell | 100% Buy | 80% Buy |
| Previous Opinion | 72% Sell | 72% Sell | 8% Sell | 100% Buy | 88% Buy |
| Last Month's Opinion | 80% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.76% since 12/04/24 | -1.74% since 12/04/24 | +0.93% since 12/04/24 | +0.86% since 12/04/24 | -2.95% since 12/04/24 |
| Low | 3.22 on 12/10/24 | 270.58 on 12/11/24 | 456.86 on 12/06/24 | 90.50 on 12/09/24 | 56.62 on 12/11/24 |
| High | 3.85 on 12/05/24 | 280.00 on 12/09/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 59.76 on 12/09/24 |
| 1-Month | |||||
| %Chg | -2.52% since 11/11/24 | -15.04% since 11/11/24 | -6.66% since 11/11/24 | -4.79% since 11/11/24 | -5.30% since 11/11/24 |
| Low | 2.20 on 11/19/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 | 55.82 on 11/15/24 |
| High | 4.50 on 12/03/24 | 321.22 on 11/12/24 | 508.04 on 11/12/24 | 96.84 on 11/12/24 | 60.68 on 11/25/24 |
| 3-Month | |||||
| %Chg | -13.44% since 09/11/24 | -17.14% since 09/11/24 | -1.36% since 09/11/24 | +14.13% since 09/11/24 | +16.59% since 09/11/24 |
| Low | 2.20 on 11/19/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 81.57 on 09/13/24 | 47.76 on 09/12/24 |
| High | 5.45 on 10/23/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -34.85% since 06/11/24 | -9.08% since 06/11/24 | -2.75% since 06/11/24 | +42.36% since 06/11/24 | +31.68% since 06/11/24 |
| Low | 2.20 on 11/19/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 | 39.35 on 07/05/24 |
| High | 5.45 on 10/23/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 70,963 | 148,224,736 | 120,837,752 | 115,080,200 | 117,877,648 |
| Shares Outstanding, K | 20,569 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 15,730,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -72,730,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 1,070,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -30,440,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.64 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.80 on 11/06/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/12/24 | 02/04/25 | 02/03/25 | 02/04/25 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 0.00 | 20.45 | 50.18 |